-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The synthesis of natural products is an important area of research in the chemical industry.
One such natural product that has recently gained interest is (2β,4α,15α)-15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid.
This compound is a type of kaurene, a class of natural products that are known for their unique structure and biological activity.
In this article, we will discuss the synthetic routes that have been developed for the synthesis of this compound.
One of the earliest synthetic routes for the synthesis of (2β,4α,15α)-15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid involved the use of an enolate intermediate.
This method involved the condensation of 2-chloro-3-methyl-1-oxobutene with 3-O-benzylidene-4-O-benzylidene-2-O-benzylidenecyclohexane-1,2-diol in the presence of a strong base, such as sodium hydride.
The resulting enolate was then treated with a sulfonate ester, such as 3,4-di-O-sulfo-β-D-glucopyranosyl sulfate, to form the desired sulfate ester.
This sulfate ester was then transformed into the final product by a series of chemical reactions, including hydrolysis and oxidation.
A more recent synthetic route for the synthesis of (2β,4α,15α)-15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid has been developed by a team of researchers from the Institute of Molecular and Cellular Biology in Japan.
This method involves the use of a Grignard reagent as a key intermediate.
The Grignard reagent is generated by the reaction of magnesium metal with a halogenated alkane, such as 2-chloro-3-methyl-1-oxobutene.
The Grignard reagent is then treated with a sulfonate ester, such as 3,4-di-O-sulfo-β-D-glucopyranosyl sulfate, to form the desired sulfate ester.
This sulfate ester is then transformed into the final product by a series of chemical reactions, including hydrolysis and oxidation.
One advantage of the synthetic routes described above is that they allow for the synthesis of (2β,4α,15α)-15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid in a scalable and efficient manner.
However, these methods do have some limitations.
For example, the use of strong bases and reactive reagents can make these methods potentially hazardous.
In addition, the synthesis of the Grignard reagent can be challenging and requires specialized equipment.
Overall, the synthetic routes described above represent important advances in the synthesis of (2β,4α,15α)-15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid.
These methods provide valuable tools for